Narendra D. Lalwani
2014
In 2014, Narendra D. Lalwani earned a total compensation of $3.2M as Executive Vice President, Research and Development and Chief Operating Officer at Esperion Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $70,000 |
|---|---|
| Option Awards | $2,842,054 |
| Salary | $150,000 |
| Other | $146,750 |
| Total | $3,208,804 |
Lalwani received $2.8M in option awards, accounting for 89% of the total pay in 2014.
Lalwani also received $70K in non-equity incentive plan, $150K in salary and $146.8K in other compensation.
Rankings
In 2014, Narendra D. Lalwani's compensation ranked 2,815th out of 13,032 executives tracked by ExecPay. In other words, Lalwani earned more than 78.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,815 out of 13,032 | 78th |
Division Manufacturing | 997 out of 4,966 | 80th |
Major group Chemicals And Allied Products | 317 out of 1,686 | 81st |
Industry group Drugs | 247 out of 1,365 | 82nd |
Industry Pharmaceutical Preparations | 204 out of 1,043 | 80th |
Source: SEC filing on March 6, 2017.
Lalwani's colleagues
We found two more compensation records of executives who worked with Narendra D. Lalwani at Esperion Therapeutics in 2014.